Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Alternate title: 
J2 - Ann Oncol
Secondary title: 
T2 - Annals of oncology
Short title: 
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Authors: 
Stahel, R. A.
Weder, W.
Lievens, Y.
Felip, E.
Group, Esmo Guidelines Working
Volume: 
21 Suppl 5
Start page: 
v126-8
Annotations: 
Type D, Priority 5
Date: 
May
Year: 
2010
Accession number: 
20555061
Database: 
MEDLINE Cohort
Serial: 
1569-8041
Type of work: 
M3 - Practice Guideline
ID: 
13042
DOI: 
http://dx.doi.org/10.1093/annonc/mdq173
Notes: 
N1 - Stahel RA Weder W Lievens Y Felip E ESMO Guidelines Working Group
Key words: 
Antineoplastic Combined Chemotherapy Protocols/tu [Therapeutic Use]
Chemotherapy, Adjuvant
Combined Modality Therapy
Europe/ep [Epidemiology]
Follow-Up Studies
Humans
Incidence
*Mesothelioma/di [Diagnosis]
Mesothelioma/pa [Pathology]
*Mesothelioma/th [Therapy]
Neoplasm Staging
Palliative Care
*Pleural Neoplasms/di [Diagnosis]
Pleural Neoplasms/pa [Pathology]
*Pleural Neoplasms/th [Therapy]
Pneumonectomy
Radiotherapy
Randomized Controlled Trials as Topic
Recurrence
Thoracoscopy
Treatment Outcome
Tumor Markers, Biological/bl [Blood]
0 (Tumor Markers, Biological)
Types of evidence: 
Type D
Priorities of Care: 
Priority 5: Plan and do